Have a personal or library account? Click to login
Comparison of Hypertension in Migrant and Local Patients with Atherosclerotic Diseases: A Cross-Sectional Study in Shanghai, China Cover

Comparison of Hypertension in Migrant and Local Patients with Atherosclerotic Diseases: A Cross-Sectional Study in Shanghai, China

Annals of Global Health
Volume 86 (2020): Issue 1
By: Xin Gong,  Jianwei Shi,  Jiaoling Huang,  Wenya Yu,  Xiaojie Bo,  Kangjie Xu,  Ning Chen,  Qian Liu,  Chen Chen and  Zhaoxin Wang  
Open Access
|Feb 2020

References

  1. 1Goodarz D, Lu Y, Singh GM, et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014; 2: 634–47. DOI: 10.1016/S2213-8587(14)70102-0
    Back to article
  2. 2Hill C. Death registrations in England and Wales, 2008, causes. Health Statistics Quarterly. 2009; 43: 68–76. DOI: 10.1057/hsq.2009.30
    Back to article
  3. 3Czernichow S, Zanchetti A, Turnbull F, Barzi F, Ninomiya T, Kengne AP, et al. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials. J Hypertension. 2011; 29: 4–16. DOI: 10.1097/HJH.0b013e32834000be
    Back to article
  4. 4American Heart Association, Inc. Social Determinants of Risk and Outcomes for Cardiovascular Disease. Circulation. 2015; 132: 873–898. DOI: 10.1161/CIR.0000000000000228
    Back to article
  5. 5Wenying Y, Juming L, Jianping W, et al. Prevalence of diabetes among men and women in China. The New England Journal of Medicine. 2010; 362: 1090–1101. DOI: 10.1056/NEJMoa0908292
    Back to article
  6. 6Xu Y, Wang L, Xu B, et al. Prevalence, Awareness, Treatment, and Control of Diabetes in Relation with Hypertension Status in Chinese Adults: A Nationwide Cross-Sectional Survey. DIABETES. 2016; 65: 365–366.
    Back to article
  7. 7Zhao D, Liu J, Xie W, Qi Y. Cardiovascular risk assessment: A global perspective. Nature Reviews Cardiology. 2015; 12: 301–311. DOI: 10.1038/nrcardio.2015.28
    Back to article
  8. 8Benetos A, Petrovic M, Strandberg T. Hypertension Management in Older and Frail Older Patients. Circ Res. 2019; 124: 1045–1060. DOI: 10.1161/CIRCRESAHA.118.313236
    Back to article
  9. 9Zaninotto P, Mindell J, Hirani V. Prevalence of cardiovascular risk factors among ethnic groups: results from the Health Surveys for England. Atherosclerosis. 2007; 195: 48–57. DOI: 10.1016/j.atherosclerosis.2007.02.017
    Back to article
  10. 10Chiu M, Austin PC, Manuel DG, Tu JV. Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. CMAJ. 2010; 182: 301–310. DOI: 10.1503/cmaj.091676
    Back to article
  11. 11Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009; 8: 345–354. DOI: 10.1016/S1474-4422(09)70023-7
    Back to article
  12. 12Sharma S, Malarcher AM, Giles WH, Myers G. Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Disease. 2004; 14: 43–48.
    Back to article
  13. 13Priyanka RG, Salam K, Huidrom SS, et al. Differences in conventional cardiovascular risk factors in two ethnic groups in India. Ethn Dis. 2012; 6(22): 372–376.
    Back to article
  14. 14Ying Tao, Yi-tong Ma, Yang Xiang, Xiang Xie, Yi-ning Yang, Xiao-mei Li, et al. Prevalence of major cardiovascular risk factors and adverse risk profiles among three ethnic groups in the Xinjiang Uygur Autonomous Region, China. Lipids in Health and Disease. 2013; 12: 185–191. DOI: 10.1186/1476-511X-12-185
    Back to article
  15. 15NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017; 389: 37–55. DOI: 10.1016/S0140-6736(16)31919-5
    Back to article
  16. 16Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012; 380: 611–619. DOI: 10.1016/S0140-6736(12)60861-7
    Back to article
  17. 17Modesti PA, Calabrese M, Marzotti I, Bing H, Malandrino D, Boddi M, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017; 390: 2549–2558. DOI: 10.1016/S0140-6736(17)32478-9
    Back to article
  18. 18Vasileva K. 6.5% of the EU population are foreigners and 9.4% are born abroad. Eurostat: Statistics in Focus. 2011; 34: 1–8.
    Back to article
  19. 19Bernd R, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2013; 381: 1235–1245. DOI: 10.1016/S0140-6736(12)62086-8
    Back to article
  20. 20Kusuma YS. Perceptions on hypertension among migrants in Delhi, India: a qualitative study. BMC Public Health. 2009; 9: 267–275. DOI: 10.1186/1471-2458-9-267
    Back to article
  21. 21Bernabe-Ortiz A, Sanchez JF, Carrillo-Larco RM, Gilman RH, Potericol JA, Quispe R, et al. Rural-to-urban migration and risk of hypertension: longitudinal results of the PERU MIGRANT study. Journal of Human Hypertension. 2017; 31: 22–28. DOI: 10.1038/jhh.2015.124
    Back to article
  22. 22Agyemang C, Nyaaba G, Beune E, Meeks K, Owusu-Dabo E, Addo J, et al. Variations in hypertension awareness, treatment, and control among Ghanaian migrants living in Amsterdam, Berlin, London, and nonmigrant Ghanaians living in rural and urban Ghana – the RODAM study. Journal of Hypertension. 2018; 36: 169–177. DOI: 10.1097/HJH.0000000000001520
    Back to article
  23. 23Shanghai Statistical Yearbook. 2016.
    Back to article
  24. 24Whelton PK, Carey RM. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2017; 71: 140–144. DOI: 10.1161/HYP.0000000000000065
    Back to article
  25. 25Modesti PA, Calabrese M, Marzotti I, et al. Prevalence, awareness, treatment, and control of hypertension among Chinese first-generation migrants and Italians in Prato, Italy: The CHIP study. International Journal of Hypertension. 2017; 2017: 1–8. DOI: 10.1155/2017/6402085
    Back to article
  26. 26Fang J, Zhao G, Wang G, Ayala C, Loustalot F. Insurance status among adults with hypertension—The impact of underinsurance. Journal of the American Heart Association. 2016; 5: e004313. DOI: 10.1161/JAHA.116.004313
    Back to article
  27. 27Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet. 2011; 377: 568–77. DOI: 10.1016/S0140-6736(10)62036-3
    Back to article
  28. 28Zaninotto P, Mindell J, Hirani V. Prevalence of cardiovascular risk factors among ethnic groups: results from the Health Surveys for England. Atherosclerosis. 2007; 195: 48–57. DOI: 10.1016/j.atherosclerosis.2007.02.017
    Back to article
  29. 29Zhao W, Katzmarzyk PT, Horswell K. HbA1c and coronary heart disease risk among diabetic patients. Diabetes Care. 2014; 37: 428–435. DOI: 10.2337/dc13-1525
    Back to article
  30. 30Uthman M, Qaisar AM, Anwar A, Ullah Z. Coexistence of hypertension in type 2 diabetes mellitus patients (co-tension-D2-study). Pakistan Journal of Medical and Health Sciences. 2015; 9: 360–363.
    Back to article
  31. 31Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients: a cross-sectional hospital-based survey in urban China. Health Qual Life Outcomes. 2010; 8: 62–65. DOI: 10.1186/1477-7525-8-62
    Back to article
  32. 32Shantsila A, Shantsila E, Beevers DG, Lip GYH. Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham malignant hypertension registry. Journal of Hypertension. 2017; 35: 2310–2314. DOI: 10.1097/HJH.0000000000001446
    Back to article
  33. 33Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Heerspink HJL, et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet. 2012; 380: 1662–1673. DOI: 10.1016/S0140-6736(12)61350-6
    Back to article
  34. 34Meisinger C, Doring A, Lowel H, KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J. 2006; 27: 1245–1250. DOI: 10.1093/eurheartj/ehi880
    Back to article
  35. 35Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010; 375: 2073–2081. DOI: 10.1016/S0140-6736(10)60674-5
    Back to article
  36. 36Singh GM, Danaei G, Pelizzari PM, et al. The age associations of blood pressure, cholesterol, and glucose: analysis of health examination surveys from international populations. Circulation. 2012; 125: 2204–2211. DOI: 10.1161/CIRCULATIONAHA.111.058834
    Back to article
DOI: https://doi.org/10.5334/aogh.2635 | Journal eISSN: 2214-9996
Journal RSS Feed
Language: English
Published on: Feb 28, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Xin Gong, Jianwei Shi, Jiaoling Huang, Wenya Yu, Xiaojie Bo, Kangjie Xu, Ning Chen, Qian Liu, Chen Chen, Zhaoxin Wang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 86 (2020): Issue 1Next article